March 20, 2013 at 10:24 AM EDT
Merck Serono and BMS Team Up to Offer Diabetes Drug to China
Merck Serono, a division of Merck KGaA, will collaborate with Bristol-Myers Squibb to promote China distribution of Glucophage®, the type 2 diabetes treatment known generically as metformin. Merck Serono discovered metformin in 1957. However, Bristol-Myers Squibb-SASS has been distributing the immediate-release formulation of the drug in China since 1999. The two companies will also introduce newer formulations of the drug to China. More details.... Stock Symbols: (F: MRK) (NYSE: BMY) Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here